Horse Sweet Itch ASIT Outcomes: Evidence and Expectations

Allergen-specific immunotherapy for sweet itch offers sustained relief for some horses, but outcomes vary and realistic expectations are important.

Key Facts

Sweet itch is caused by hypersensitivity to Culicoides midge saliva and affects 2-5% of horses in the UK.
ASIT involves injecting gradually increasing doses of Culicoides allergen extract to desensitise the immune system.
Published studies report 60-70% of horses show meaningful improvement with ASIT over 1-3 treatment seasons.
ASIT does not eliminate sensitivity but reduces the severity of the inflammatory response.
Treatment requires intradermal skin testing to identify relevant allergen concentrations before starting.
ASIT must be combined with physical midge avoidance — rugs, stabling at dusk and dawn — for best results.

Welfare Considerations

Sweet itch causes severe pruritus, self-trauma, and secondary skin damage that persists throughout midge season. It is a major welfare problem for affected horses. ASIT offers genuine long-term benefit for many horses but is not a cure and must be combined with management measures. Realistic owner expectations and committed management compliance are essential for achieving good welfare outcomes.

What You Can Do

Discuss ASIT referral with your vet if sweet itch is not adequately controlled by current management.
Use physical barriers — specialist rugs and stabling at midge-active times — alongside any treatment.
Be realistic about ASIT outcomes; improvement takes 1-2 seasons to develop fully.
Monitor skin condition and pruritus intensity across seasons to assess treatment response objectively.